View Single Post
Old 07-22-2009, 09:30 PM
caldeerster caldeerster is offline
Junior Member
 
Join Date: Aug 2007
Posts: 81
15 yr Member
caldeerster caldeerster is offline
Junior Member
 
Join Date: Aug 2007
Posts: 81
15 yr Member
Default It's been almost two years, why isn't this peptide in human trials yet?

If someone is reading this from MJF, can you tell us what is going on with this?

Thanks.

Researchers Use Peptide to Halt Progression of Parkinson's Disease
November 23, 2007 by Regina Sass

In a joint research project from the Rush University Medical Center, the University of Nebraska Medical Center, Omaha, and Yale University, New Haven, scientists have been able to use a peptide to successfully reverse the biochemical, cellular and anatomical changes associated with Parkinson's disease in mice and thereby have been able to prevent the disease from progressing any further.

The study has revealed that one particular protein, NF-kB, is present in increased level in the midbrain region in Parkinson's disease and that mice with Parkinson's disease pathology. They used a novel peptide, which is a small protein, to block the protein in the mice who had symptoms of Parkinson's disease.

After they injected the peptide into the abdomens of the mice, it made its way to the brain and blocked not only the protein NF-kB, but also other toxic molecules. It then went on to protect neurons, normalize neurotransmitter levels, and improve motor functions.

http://www.associatedcontent.com/art...ogression.html
caldeerster is offline   Reply With QuoteReply With Quote